NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
Redx Pharma Plc (LSE: REDX)
REDX Technical Analysis
5
As on 30th Apr 2024 REDX STOCK Price closed @ 15.00 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 37.01 & Strong Sell for SHORT-TERM with Stoploss of 57.99 we also expect STOCK to react on Following IMPORTANT LEVELS. |
REDXSTOCK Price
Open | 11.50 | Change | Price | % |
High | 31.95 | 1 Day | 3.60 | 31.58 |
Low | 11.41 | 1 Week | 3.00 | 25.00 |
Close | 15.00 | 1 Month | -5.50 | -26.83 |
Volume | 1396309 | 1 Year | -43.00 | -74.14 |
52 Week High 64.50 | 52 Week Low 4.25 |
LSE UK Most Active Stocks
NTOG | 0.02 | -50.00% |
TRP | 0.03 | 0.00% |
VELA | 0.01 | % |
MSMN | 0.04 | 0.00% |
UKOG | 0.02 | 0.00% |
RRR | 0.04 | 0.00% |
DKE | 0.15 | 0.00% |
NNN | 0.09 | 50.00% |
DMTR | 0.03 | 0.00% |
BOIL | 0.08 | 0.00% |
LSE UK Top Gainers Stocks
LSE UK Top Losers Stocks
REDX Daily Charts |
REDX Intraday Charts |
Whats New @ Bazaartrend |
REDX Free Analysis |
|
REDX Important Levels Intraday
RESISTANCE | 54.58 |
RESISTANCE | 41.89 |
RESISTANCE | 34.04 |
RESISTANCE | 26.19 |
SUPPORT | 3.81 |
SUPPORT | -4.04 |
SUPPORT | -11.89 |
SUPPORT | -24.58 |
REDX Forecast November 2024
4th UP Forecast | 47.37 |
3rd UP Forecast | 36.99 |
2nd UP Forecast | 30.57 |
1st UP Forecast | 24.16 |
1st DOWN Forecast | 5.84 |
2nd DOWN Forecast | -0.57 |
3rd DOWN Forecast | -6.99 |
4th DOWN Forecast | -17.37 |
REDX Weekly Forecast
4th UP Forecast | 22.71 |
3rd UP Forecast | 20.24 |
2nd UP Forecast | 18.71 |
1st UP Forecast | 17.18 |
1st DOWN Forecast | 12.82 |
2nd DOWN Forecast | 11.29 |
3rd DOWN Forecast | 9.76 |
4th DOWN Forecast | 7.29 |
REDX Forecast2024
4th UP Forecast | 136.4 |
3rd UP Forecast | 97.47 |
2nd UP Forecast | 73.4 |
1st UP Forecast | 49.34 |
1st DOWN Forecast | -19.34 |
2nd DOWN Forecast | -43.4 |
3rd DOWN Forecast | -67.47 |
4th DOWN Forecast | -106.4 |
Redx Pharma Plc ( LSE UK Symbol : REDX )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
REDX Other Details
Segment | EQ | |
Market Capital | 225731232.00 | |
Sector | Healthcare | |
Industry | Biotechnology | |
Offical website | > echo $website ; ?> |
REDX Address
REDX Latest News
REDX Business Profile
Redx Pharma Plc engages in drug discovery, pre-clinical development, and licensing activities in the United Kingdom. It discovers and develops small molecule drugs for treating anti-cancer and fibrosis targets in the areas of unmet medical needs. The company is developing RXC004, a porcupine inhibitor, which has completed Phase I clinical development for the treatment of colorectal, pancreatic, biliary, and gastric cancers, as well as melanoma; ROCK inhibitor for treating inflammatory intestinal fibrosis; RXC007, a Rho-associated protein kinase 2 inhibitors for the treatment of orphan disease, idiopathic pulmonary fibrosis, non-alcoholic steatohepatitis, and other systemic fibrotic conditions; and Porcupine (RXC006), which is in Phase I for the treatment of lung fibrosis. Redx Pharma Plc has a research collaboration agreement with Jazz Pharmaceuticals plc to discover and develop drug candidates for two cancer targets in the Ras/Raf/MAP kinase pathway. The company was founded in 2010 and is based in Macclesfield, the United Kingdom. Address: Alderley Park, Macclesfield, United Kingdom, SK10 4TG
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service